Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

this weeks' manuscripts on covid-19 & psoriasis

Related Articles

Novel Coronavirus Disease (COVID-19) and Biologic Therapy for Psoriasis: Successful Recovery in Two Patients After Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).

Dermatol Ther (Heidelb). 2020 May 29;:

Authors: Brownstone ND, Thibodeaux QG, Reddy VD, Myers BA, Chan SY, Bhutani T, Liao W

Abstract
The outbreak of the novel coronavirus known as SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) causing COVID-19 was first reported in late December 2019. Many patients with psoriasis on biologic therapy have asked their medical providers about the effect of biologics on COVID-19. However, it is currently unknown how biologic therapy for psoriasis might impact patients with psoriasis and COVID-19. In this article, we report on the clinical course of two patients on biologic medication for psoriasis who developed COVID-19 and successfully recovered from SARS-CoV-2 infection. Both patients presented with fever and respiratory symptoms, but neither patient required hospitalization. While more research is needed, it is reassuring to know that successful recovery is possible after COVID-19 infection in patients on biologic therapy for psoriasis.

PMID: 32468230 [PubMed - as supplied by publisher]

More

Other relevant manuscripts
IPC's Chief Medical Officer has selected the following manuscripts as important to the understanding of the impact of COVID-19 and psoriasis. 

selections for week of may 18, 2020 

The risk of respiratory tract infections and symptoms in psoriasis patients treated with IL-17-pathway inhibiting biologics: A metaestimate of pivotal trials relevant to decision-making during the COVID-19 pandemic.  Wan MT, Shin DB, Winthrop KL, Gelfand JM. Journal of the American Academy of Dermatology. 2020. doi: https://doi.org/10.1016/j.jaad.2020.05.035.

Practice guidelines for teledermatology in Australia. Abbott LM, Miller R, Janda M, Bennett H, Taylor M, Arnold C, Shumack S, Soyer HP, Caffery LJ. Australas. J Dermatol. 2020 May 3. doi: 10.1111/ajd.13301. [Epub ahead of print]


View all

resources from our industry partners

 AbbVie

Amgen

Novartis

UCB



We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.
OK